XML 15 R6.htm IDEA: XBRL DOCUMENT v3.22.2
CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY (Unaudited) - USD ($)
shares in Millions, $ in Millions
Total
Common Stock
Treasury Shares
Paid-In Capital
Accumulated Other Comprehensive Income
Retained Earnings
Beginning balance (in shares) at Dec. 31, 2020   478        
Beginning balance (in shares) at Dec. 31, 2020     79      
Balance at beginning of period at Dec. 31, 2020 $ 2,216 $ 48 $ (1,823) $ 1,804 $ 2 $ 2,185
Increase (Decrease) in Stockholders' Equity            
Net income 126         126
Stock amortization and vesting 4     4    
Common stock cash dividends (40)         (40)
Ending balance (in shares) at Mar. 31, 2021   478        
Ending balance (in shares) at Mar. 31, 2021     79      
Balance at end of period at Mar. 31, 2021 2,306 $ 48 $ (1,823) 1,808 2 2,271
Beginning balance (in shares) at Dec. 31, 2020   478        
Beginning balance (in shares) at Dec. 31, 2020     79      
Balance at beginning of period at Dec. 31, 2020 2,216 $ 48 $ (1,823) 1,804 2 2,185
Increase (Decrease) in Stockholders' Equity            
Net income 156          
Ending balance (in shares) at Jun. 30, 2021   478        
Ending balance (in shares) at Jun. 30, 2021     79      
Balance at end of period at Jun. 30, 2021 2,300 $ 48 $ (1,823) 1,816 2 2,257
Beginning balance (in shares) at Dec. 31, 2020   478        
Beginning balance (in shares) at Dec. 31, 2020     79      
Balance at beginning of period at Dec. 31, 2020 2,216 $ 48 $ (1,823) 1,804 2 2,185
Increase (Decrease) in Stockholders' Equity            
Treasury stock repurchases (27)          
Ending balance (in shares) at Dec. 31, 2021   893        
Ending balance (in shares) at Dec. 31, 2021     79      
Balance at end of period at Dec. 31, 2021 11,738 $ 89 $ (1,826) 10,911 1 2,563
Beginning balance (in shares) at Mar. 31, 2021   478        
Beginning balance (in shares) at Mar. 31, 2021     79      
Balance at beginning of period at Mar. 31, 2021 2,306 $ 48 $ (1,823) 1,808 2 2,271
Increase (Decrease) in Stockholders' Equity            
Net income 30         30
Stock amortization and vesting 8     8    
Common stock cash dividends (44)         (44)
Ending balance (in shares) at Jun. 30, 2021   478        
Ending balance (in shares) at Jun. 30, 2021     79      
Balance at end of period at Jun. 30, 2021 2,300 $ 48 $ (1,823) 1,816 2 2,257
Beginning balance (in shares) at Dec. 31, 2021   893        
Beginning balance (in shares) at Dec. 31, 2021     79      
Balance at beginning of period at Dec. 31, 2021 11,738 $ 89 $ (1,826) 10,911 1 2,563
Increase (Decrease) in Stockholders' Equity            
Net income 608         608
Exercise of stock options 6     6    
Stock amortization and vesting $ 10     10    
Treasury stock repurchases (in shares) 8          
Treasury stock repurchases $ (192)          
Common stock cash dividends (455)         (455)
Preferred stock dividends (1)         (1)
Other comprehensive income 4       4  
Ending balance (in shares) at Mar. 31, 2022   893        
Ending balance (in shares) at Mar. 31, 2022     87      
Balance at end of period at Mar. 31, 2022 11,718 $ 89 $ (2,018) 10,927 5 2,715
Beginning balance (in shares) at Dec. 31, 2021   893        
Beginning balance (in shares) at Dec. 31, 2021     79      
Balance at beginning of period at Dec. 31, 2021 11,738 $ 89 $ (1,826) 10,911 1 2,563
Increase (Decrease) in Stockholders' Equity            
Net income $ 1,837          
Treasury stock repurchases (in shares) 20          
Treasury stock repurchases $ (513)          
Ending balance (in shares) at Jun. 30, 2022   894        
Ending balance (in shares) at Jun. 30, 2022     99      
Balance at end of period at Jun. 30, 2022 12,191 $ 89 $ (2,339) 10,976 5 3,460
Beginning balance (in shares) at Mar. 31, 2022   893        
Beginning balance (in shares) at Mar. 31, 2022     87      
Balance at beginning of period at Mar. 31, 2022 11,718 $ 89 $ (2,018) 10,927 5 2,715
Increase (Decrease) in Stockholders' Equity            
Net income 1,229         1,229
Exercise of stock options 3     3    
Stock amortization and vesting 18     18    
Conversion of Cimarex redeemable preferred stock (in shares)   1        
Conversion of Cimarex redeemable preferred stock 28     28    
Treasury stock repurchases (in shares)     12      
Treasury stock repurchases (321)   $ (321)      
Common stock cash dividends (484)         (484)
Other comprehensive income 0          
Ending balance (in shares) at Jun. 30, 2022   894        
Ending balance (in shares) at Jun. 30, 2022     99      
Balance at end of period at Jun. 30, 2022 $ 12,191 $ 89 $ (2,339) $ 10,976 $ 5 $ 3,460